Phospholipid deformable vesicles for buccal delivery of insulin

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 6, 2002, Pages 749-753

  Yang, Tian Zhi ^a   Wang, Xiang Tao ^a   Yan, Xue Ying ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Buccal delivery; Deformable vesicle; Insulin; Relative bioavailability; Relative pharmacological bioavailability

Indexed keywords

CHOLESTEROL; DEOXYCHOLATE SODIUM; DRUG CARRIER; INSULIN; LIPOSOME; PHOSPHATIDYLCHOLINE; ANTIDIABETIC AGENT; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CHEEK MUCOSA; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFECT; DRUG MIXTURE; DRUG SCREENING; EVAPORATION; HYPOGLYCEMIA; MALE; MICROMORPHOLOGY; NONHUMAN; PARTICLE SIZE; RABBIT; REVERSED PHASE LIQUID CHROMATOGRAPHY; ANIMAL; ANIMAL MODEL; BIOAVAILABILITY; BLOOD; BUCCAL DRUG ADMINISTRATION; CHEEK; CHEMISTRY; GLUCOSE BLOOD LEVEL; PHYSIOLOGY;

ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHEEK; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MODELS, ANIMAL; PHOSPHOLIPIDS; RABBITS;

EID: 0036593597     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.749     Document Type: Article

References (36)

1. Junginger H. E., Hoogstraate J. A., Verhoef J. C., J. Controll. Res., 62, 149-159 (1999).
2. Rathbone M. J., Ponchel G., Ghazalil A., "Oral Mucosal Drug Delivery," Marcel Dekker, New York, 1996, pp. 242-253.
3. Lee V. H., Biochem. Soc. Trans., 17, 937-940 (1989).
4. Wearly L. L., Crit. Rev. Ther. Drug Carrier Syst., 8, 331-394 (1991).
5. Farshi F. S., Ozen A. Y., Ercan M. T., Hincal A. A., J. Microencapsul., 13, 537-544 (1996).
6. Betageri G. V., Jenkins S. A., Parsons D. L., "Liposome Drug Delivery Systems," Technomic, Lancaster/Basel, 1993, pp. 65-88.
7. Al-Achi A., Greenwoood R., Res. Commun. Chem. Pathol. Pharmacol., 82, 297-306 (1993).
8. Veuillez F., Deshusses J., Buri P., Eur. J. Pharm. Biopharm., 48, 21-26 (1999).
9. Paul A., Eur. J. Immunol., 2, 3521-3524 (1995).
10. Cevc G., Blume G., Biochim. Biophys. Acta, 1514, 191-205 (2001).
11. Planas M. E., Gonzalez P., Rodriguez L., Sanchez S., Cevc G., Anesth. Analg., 75, 615-621 (1992).
12. Cevc G., Blume G., Schatzlein A., Gebauer D., Paul A., Adv. Drug Deliv. Rev., 18, 349-378 (1996).
13. Cevc G., Blume G., Schatzlein A., J. Controll. Res., 45, 211-226 (1997).
14. Gamal M., Maghraby M. E., Adrian C., Williams B. W. B., Int. J. Pharmaceut., 196, 63-74 (2000).
15. Nagai T., Machida Y., Adv. Drug Deliv. Rev., 11, 179-191 (1993).
16. Aungst B. J., Rogers N. J., Int. J. Pharmaceut., 53, 227-235 (1989).
17. Shen Z. C., Zhang Q., Wei S. L., Int. J. Pharmaceut., 192, 115-121 (1999).
18. Hayakawa E., Yamamoto A., Shoji Y., Lee V. H., Life Sci., 45, 167-174 (1989).
19. Yamamoto A., Taniguchi T., Rikyuum K., Tsuji T., Fujita T., Murakami M., Muranish S., Pharm. Res., 11, 1496-1500 (1994).
20. Shojaei A. H., J. Pharm. Sci., 1, 15-30 (1998).
21. Siegel I. A., Gordon H. P., Exp. Mol. Pathol., 44, 132-137 (1986).
22. Dowty M. E., Knuth K. E., Robinson J. R., Pharm. Res., 9, 1113-1122 (1992).
23. Oh C. K., Ritschel E. A., Meth. Find. Exp. Clin. Pharmacol., 12, 205-211 (1990).
24. Liu J. C., Sun Y., Siddiqui O., Int. J. Pharmaceut., 44, 197-204 (1988).
25. Abraham W., Downing D. T., Biochim. Biophys. Acta, 1021, 119-125 (1990).
26. Callaghan T. M., Metezeau P., Gachelin H., Redziniak G., Milner Y., Goldberg M. E., J. Invest. Dermatol., 94, 58-64 (1990).
27. Guo J. X., Ping Q. N., Sun G. Q., Jiao C. H., Int. J. Pharmaceut., 194, 201-207 (2000).
28. Cevc G., Gebauer D., Stieber J., Schatzlein A., Blume G., Biochim. Biophys. Acta, 1368, 201-215 (1998).
29. Kirjavainen M., Urtti A., Jaaskelainen I., Biochim. Biophys. Acta, 1304, 179-189 (1996).
30. Ulmius J., Lindblom G., Wennerstrom H., Biochemistry, 21, 1553-1560 (1982).
31. Schubert R., Beyer K., Wolburg H., "Liposomes as Drug Carrier," ed. by Schmidt K. H., Georg Rieme Verlag, Stuttart, New York, 1986, pp. 61-73.
32. Duchateau J., Zuidema F., Merkus W. H., Int. J. Pharmaceut., 31, 193-199 (1986).
33. Gordon G. S., Moses A. C., Silver R. D., Flier J. S., Carey M. C., Proc. Natl. Acad. Sci. U.S.A., 82, 7419-7423 (1985).
34. Merkle H. P., Wolany G. J. M., J. Controll. Res., 21, 155-164 (1992).
35. Garren K. W., Repta A. J., Int. J. Pharmaceut., 48, 189-194 (1988).
36. Tucker I. G., J. Pharm. Pharmacol., 40, 679-683 (1988).